

Dr Oseme Etomi
Dr Oseme Etomi is an obstetric physician in London, UK, and works across three National Health System (NHS) trusts including Guy’s and St Thomas’, King’s and the Queen Elizabeth NHS hospital trusts.
Her background is in rheumatology and general medicine and her main field of interest is in obstetric rheumatology, looking after women with inflammatory rheumatic diseases (IRDs) in pregnancy.
Dr Etomi was trained in some of London’s most prestigious rheumatology centres, including the Royal Free Hospital (National Centre for Scleroderma and Other Connective Tissue Disorders) and Barts Health NHS Trust and the Royal London Hospital (National Centre of Inflammatory Arthritis and Systemic Lupus Erythematosus).
In 2017, Dr Etomi undertook a clinical fellowship at St Thomas’ Hospital, and she now runs a weekly Rheumatic Disease in Pregnancy clinic, seeing patients with the whole spectrum of IRDs.
Dr Etomi has published numerous abstracts and papers on IRDs and pregnancy. In 2018, she was awarded the best oral presentation at the International Society of Obstetric Medicine (ISOM) for her work in this field.
Dr Etomi was instrumental in setting up the British Society of Rheumatology (BSR) Special Interest Group in Pregnancy in 2019. She sits on the advisory board for the Biologics in Rheumatoid Arthritis in Pregnancy (BiRAP) group and is currently one of the organisers of the 12th Rheumapreg Symposium in September 2023 in London.

Evidence-based approach to medical management based on the European guidelines for HS
Latest evidence-based strategies for effective HS medical management including antibiotics and biologic therapy

Informed decisions for effective HS management
Different HS phenotypes and disease severity scores: their role in informing management decisions

The role of surgery in HS management: Optimising patient results
Surgical management of HS, through minor procedures to more complex interventions

Recognising HS symptoms: Diagnosis and what you need to know
Key criteria for diagnosing HS, common misdiagnoses and how AI can be used to assess disease severity

Taking a holistic approach: HS and its comorbidities
HS often presents with comorbidities extending beyond the skin. A holistic approach is essential for effective HS management

The invisible impact of HS: Hearing the patient experience
HS presents diverse challenges for patients, across many key aspects of life. Insights into these complex burdens provides the foundation for essential support